Mangalam Drugs & Organics Ltd - 532637 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on November 20, 2021 for Shree Kishoriju Trading and Investment Pvt Ltd Mangalam Drugs & Organics Ltd - 532637 - Standalone Un-Audited Financial Results For The Quarter And Half Year Ended September 30, 2021.
Pursuant to Regulation 30 read with part A of Schedule III of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015 (the Listing Regulations) we wish to inform that the Board of Directors of the Company at its meeting held today i.e., November 12, 2021 inter-alia considered & approved the Un-Audited Financial Results for the quarter and half year ended September 30, 2021 along with the Limited Review Report on the results pursuant to Regulation 33 of the Listing Regulations. A copy of the said results, notes thereto and Limited Review Report of the Auditor is enclosed for your records. MANGALAM DRUGS & ORGANICS LTD. - 532637 - Board Meeting Outcome for Outcome Of Board Meeting Held On Friday, November 12, 2021
Pursuant to Regulation 30 read with part A of Schedule III of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015 (the Listing Regulations) we wish to inform that the Board of Directors of the Company at its meeting held today i.e., November 12, 2021 inter-alia considered & approved the Un-Audited Financial Results for the quarter and half year ended September 30, 2021 along with the Limited Review Report on the results pursuant to Regulation 33 of the Listing Regulations. A copy of the said results, notes thereto and Limited Review Report of the Auditor is enclosed for your records. Mangalam Drugs & Organics Ltd - 532637 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on November 03, 2021 for Shree Kishoriju Trading and Investment Pvt Ltd MANGALAM DRUGS & ORGANICS LTD. - 532637 - Board Meeting Intimation for Inter-Alia To Consider And Approve The Un-Audited Financial Results Of The Company For The Quarter And Half Year Ended September 30, 2021(Q2) Scheduled To Be Held On Friday, November 12, 2021.
MANGALAM DRUGS & ORGANICS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2021 ,inter alia, to consider and approve the Un-Audited Financial Results of the Company for the quarter and half year ended September 30, 2021(Q2). MANGALAM DRUGS & ORGANICS LTD. - 532637 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on November 02, 2021 for Shree Kishoriju Trading and Investment Pvt Ltd Mangalam Drugs & Organics Ltd - 532637 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on October 13, 2021 for Shree Kishoriju Trading and Investment Pvt Ltd Mangalam Drugs & Organics Ltd - 532637 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
In terms of Regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018, as amended from time to time please find attached herewith the Compliance Certificate as received from "Link Intime India Private Limited" Registrar and Share Transfer Agent of the Company for the quarter ended September 30, 2021. Mangalam Drugs & Organics Ltd - 532637 - Shareholding for the Period Ended September 30, 2021
Mangalam Drugs & Organics Ltd has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2021. For more details, kindly Click here Mangalam Drugs & Organics Ltd - 532637 - Statement Of Investor Complaints For The Quarter Ended September 2021
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Geeta KariraDesignation :- Company Secretary and Compliance Officer